Lumito – Associated Member of PathLAKE and part of the Consortium’s highly valuable network
Lumito's application for Associate Membership of the PathLAKE Consortium has been approved. The PathLAKE Consortium is a network of leading NHS Trusts and UK universities who, in collaboration with industrial partners, are at the forefront of innovation in digital pathology. The Consortium's work includes AI-driven diagnostics to increase the efficiency and effectiveness of pathology reporting […]
Preliminary study to detect immune complex and complement deposits in renal biopsies initiated with the University Hospitals Coventry and Warwickshire in the UK
A proof of concept-study to explore the potential of Lumito's UCNP to detect immune complex and complement deposits in renal biopsies has been initiated in collaboration with University Hospitals Coventry and Warwickshire NHS Trust in the UK and a research team led by Dr. Kishore Gopalakrishnan. Obtaining a renal biopsy is an invasive procedure […]
Booth at the European Congress of Pathology – a step towards commercialisation
For the first time ever, Lumito will have its own booth at a pathology congress. Booth number 79 has been booked for the European Congress of Pathology, which will take place in Basel from 3-7 September. "We are now ready to expose our product at one of Europe's busiest trade fairs for pathologists and other […]
Letter of Intent signed with Kaivogen Oy to produce Lumito’s complete reagent kits
Lumito AB and the Finnish company Kaivogen Oy have signed a Letter of Intent to produce Lumito's immunohistochemistry reagent kit, which is part of the company's complete product offering in digital tissue analysis. The ambition is to launch the product in research laboratories in the latter part of 2022. Lumito's product consists of a scanner […]
Successful results from a pre-study completed in collaboration with Umeå University, Sweden, shows that Lumito’s technique offers better possibilities compared with other immunohistochemical methods
A now completed pre-study, initiated at the beginning of this year in collaboration with a research group at Umeå University in Sweden led by Assistant Professor Daniel Öhlund has yielded successful results. The research group intended to identify how Lumito's UCNP (Up-Converting Nano Particles) technology could be used to improve the ability to visualise protein […]
Lumito signs cooperation agreement with Optronic for 0-series production of the company’s scanner
Lumito AB and Optronic Partner pr AB have signed a cooperation agreement for the final design, industrialization and 0-series production of Lumito's first Whole Slide Imaging (WSI) scanners. The scope of the agreement is based on the delivery of 0-series production prior to Lumito's planned launch for research laboratories at the end of 2022. The […]
The scientific article “Bioconjugation of photon-upconversion nanoparticles for cancer biomarker detection and imaging” is now published in the scientific journal Nature Protocols
The scientific article entitled "Bioconjugation of photon-upconversion nanoparticles for cancer biomarker detection and imaging" is now published in the scientific journal Nature Protocols. Read the article here. Dr. Matthias Mickert, Senior Chemical Engineer at Lumito, was part of the Gorris group at the University of Regensburg, which recently moved to Masaryk University in Brno. The […]
Scientific article will be published in Nature Protocols
Ph.D. Matthias Mickert, Senior Chemical Engineer at Lumito, was part of the Gorris group at Regensburg University that recently moved to Masaryk University in Brno. The group was recently notified that their scientific paper entitled "Bioconjugation of photon-upconversion nanoparticles for cancer biomarker detection and imaging" has now been accepted in the scientific journal Nature […]
Lumito’s development team at TTP plc
Part of Lumito's development team visited the development partner TTP's (The Technology Partnership) research and development campus, outside Cambridge in the UK, this week to discuss and plan the completion of Lumito's scanner, aimed for research laboratories, which will be launched during the later part of next year. "We appreciate the opportunity to visit the […]
Images of high and stable quality offer excellent assessment possibilities
Lumito’s objective is to create high-quality stainings of tissue sections and corresponding imaging. A key effort has been to achieve a repeatable and robust staining methodology that can generate imaging that is optimal for a digital, visual evaluation. These objectives have now been achieved, according to Dr. Bo Holmqvist. Bo Holmqvist (CSO, Imagene-iT AB) has […]
